US Stock MarketDetailed Quotes
SCNI Scinai Immunotherapeutics
- 3.650
- -0.120-3.18%
Close Jan 7 15:57 ET
3.11MMarket Cap1.52P/E (TTM)
3.820High3.620Low12.12KVolume3.870Open3.770Pre Close44.82KTurnover1.73%Turnover RatioLossP/E (Static)853.00KShares8.92052wk High0.71P/B2.56MFloat Cap2.23052wk Low--Dividend TTM700.47KShs Float6199.990Historical High--Div YieldTTM5.29%Amplitude2.230Historical Low3.697Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Scinai Immunotherapeutics Stock Forum
Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.
Monday, 16th December at 9:25 am
JERUSALEM, Dec. 16, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, announced today the establishm...
I see more Quantum play this week.
$Quantum (QMCO.US)$ AWS launched QuantumEmbark. Up after hours. Small float. 0 shares LTB.
$Arqit Quantum (ARQQ.US)$ AWS launched Quantum Embark.Increased market cap which translates to stock increasing in stock value and increased confidence in the stock. Low floa...
Dow Jones· 4 mins ago
Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million
Scinai Immunotherapeutics (NASDAQ: SCNI) reported financial results for the nine months ended September 30, 2024.
The company's shareholders' equity improved to positive $10 million from negative $7.3 million, primarily due to the conversion of a EUR 26.6 million EIB loan into preferred shares.
R...
9 MINUTES AGO, 6:31 AM EDT
VIA PR NEWSWIRE
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biotechnology company known for its focus on developing inflammation and immunology (I&I) biological products, has announced successful in-vivo preclinical study results. The results pertain to its innovative anti IL-17A/F VHH antibody fragment, known as 'NanoAb', which fun...
No comment yet